IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`COALITION FOR AFFORDABLE DRUGS X LLC,
`
`Petitioner,
`
`ANACOR PHARMACEUTICALS, INC.,
`
`Patent Owner.
`
`Case No. IPR2015-01776
`
`Patent No. 7,582,621
`
`
`
`POWER OF ATTORNEY FROM PATENT OWNER
`
`ANACOR PHARMACEUTICALS, INC.
`
`DC: 5816199-1
`
`

`
`Docket No. 0369140005-US01
`
`lPR20l5-01776
`
`Pursuant to 37 CPR. § 42.10(b), Patent Owner Anacor Pharmaceuticals,
`
`Inc. hereby appoints the practitioners associated with Customer Number 26853,
`
`including the following lead and back-up counsel, as its attorneys to transact all
`
`business in the United States Patent & Trademark Office associated with the
`
`above-captioned 1nterPartes Review.
`
`A Statement Under 37 C.F.R. § 3.73(b) is submitted herewith.
`
`Back-u u Counsel
`
`Enrique D. Longton (Reg. No. 47,304)
`elongton@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202) 662-5108
`Fax: (202 778-5108
`
`
`
`
`
`
`
`
`
`
`
`
`
` Lead Counsel
`
`Andrea G. Reister (Reg. No. 36,253)
`
`
`areister@cov.com
`Postal and Hand-Delivery Address:
`
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202) 662-5141
`. Fax: (202) 778-5141
`
`
`
`The individual signing below has the authority to execute this document on
`
`behalf of Patent Owner Anacor Pharmaceuticals, Inc.
`
`Date:
`
`ii2115’
`
`/2" 7%?‘/5 2
`
`(24.4/kl a/AL: H
`
`1/!’ CCH€~*"r[/7
`
`(5‘*"<”“[
`
`Name:
`
`Title:
`
`

`
`
`
`p/E(be|ow) is authorized to act on behalfofthe assignee. ‘i 2 I5’
`
`Date
`t/P C5\(e1‘r(i‘.')' Corn/tact
`Title
`
`Under the Pa TWOTK Reduction Act of 1995. no - -
`
`PTO/SBIQB (07~O9}
`Approved for use through 07I31I2012. OMB 0651-0031
`US. Patent and Trademark Office: US. DEPARTMENT OF COMMERCE
`- uired to res nd to a collection of information unless it dis a s a valid OMB control number.
`
`STATEMENT UNDER 37 CFR 3.73§b)
`
`Applicant/Patent Owner:
`
`Stephen J. Baker et al.
`
`7,582,621
`Application No./Patent No;
`Titled:
`BORON-CONTAlNlNG SMALL MOLECULES
`
`Filed/Issue Date:
`
`September 1. 2009
`
`Anacor Pharmaceuticals, inc.
`(Name of Assignee)
`
`. a
`
`corporation
`(Type of Asslgnee. e.g,. corporation. partnership, university. govemment agency‘ etc.)
`
`states that it is:
`
`1.
`
`the assignee of the entire right, title‘ and interest in;
`
`2. D an assignee of less than the entire right, title, and interest in
`(The extent (by percentage) of its ownership interest is
`
`°/o); or
`
`3. D an assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`the patent application/patent identified above by virtue of either:
`
`A.
`
`OR
`
`An assignment from the inventor(s) of the patent application/patent identified above. The assignment was
`s
`recorded in the United States Patent and Trademark Office at Real
`017855
`
`Frame
`
`0979
`
`, or for which a copy thereof is attached.
`
`3‘ D A chain of title from the inventor(s), of the patent application/patent identified above, to the current assignee as follows:
`1. From:
`To‘
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`, Frame
`
`, or for which a copy thereof is attached.
`
`To:
`2. From:
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`, Frame
`
`, or for which a copy thereof is attached.
`
`To:
`3. From:
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`. Frame
`
`. or for which a copy thereof is attached.
`
`[1 Additional documents in the chain of title are listed on a supplemental sheet(s).
`
`As required by 37 CFR 3.73(b)(1)(i), the documentary evidence of the chain of title from the original owner to the
`assignee was, or concurrently is being. submitted for recordation pursuant to 37 CFR 3.11.
`
`[NOTE: A separate copy (is, a true copy of the original assignment document(s)) must be submitted to Assignment
`Division in accordance with 37 CFR Part 3, to record the assignment in the records of the USPTO. geg MPEP 302.08]
`
`The undersigned (whose title is
`
`/
`
`
`Signature
`,-=?‘(»4’\} 0./»4LSt'—t
`Printed or Typed Name
`
`DC: 5816200-l
`
`

`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 2nd day of September
`
`2015, the foregoing Power of Attorney from Patent Owner Anacor Pharmaceuticals,
`
`Inc., and accompanying Statement Under 37 C.F.R. § 3.73(b), was served by FedEx,
`
`a means at least as fast and reliable as Priority Mail Express®, on the following
`
`counsel of record for petitioner.
`
`Jeffrey D. Blake
`Merchant & Gould PC
`
`191 Peachtree Street NE, Suite 4300
`
`Atlanta, GA 30303
`
`Kathleen E. Ott
`
`Merchant & Gould PC
`
`1801 California Street, Suite 3300
`
`Denver, CO 80202
`
`Date: September 2, 2015
`
`Registrati n No.: 36,25